相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The effects of increasing fruit and vegetable intake in children with asthma: A randomized controlled trial
Bronwyn S. Berthon et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2021)
Stopping Denosumab
Olivier Lamy et al.
CURRENT OSTEOPOROSIS REPORTS (2019)
Certainties and Uncertainties About Denosumab Discontinuation
Elena Tsourdi et al.
CALCIFIED TISSUE INTERNATIONAL (2018)
A long-lasting bisphosphonate partially protects periprosthetic bone, but does not enhance initial stability of uncemented femoral stems: A randomized placebo-controlled trial of women undergoing total hip arthroplasty
Erik Aro et al.
JOURNAL OF BIOMECHANICS (2018)
Effects of bisphosphonates in preventing periprosthetic bone loss following total hip arthroplasty: a systematic review and meta-analysis
Jialing Shi et al.
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2018)
Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial
Tsan-Wen Huang et al.
BMC MUSCULOSKELETAL DISORDERS (2017)
Stable Fixation of a Cementless, Proximally Coated, Double Wedged, Double Tapered Femoral Stem in Total Hip Arthroplasty: A 5-Year Radiostereometric Analysis
Audrey K. Nebergall et al.
JOURNAL OF ARTHROPLASTY (2016)
No effect of risedronate on femoral periprosthetic bone loss following total hip arthroplasty A 4-year follow-up of 61 patients in a double-blind, randomized placebo-controlled trial
Olle Muren et al.
ACTA ORTHOPAEDICA (2015)
Early subsidence of shape-closed hip arthroplasty stems is associated with late revision A systematic review and meta-analysis of 24 RSA studies and 56 survival studies
Paul Van der Voort et al.
ACTA ORTHOPAEDICA (2015)
The Effect of 6 Versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON-Pivotal Fracture Trial (PFT)
Dennis M. Black et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Effect of bisphosphonates in preventing femoral periprosthetic bone resorption after primary cementless total hip arthroplasty: a meta-analysis
Xinyu Zhao et al.
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2015)
Systematic Analysis of Bisphosphonate Intervention on Periprosthetic BMD as a Function of Stem Design
Ashleen R. Knusten et al.
JOURNAL OF ARTHROPLASTY (2014)
Effect of Zoledronic Acid on Reducing Femoral Bone Mineral Density Loss following Total Hip Arthroplasty Preliminary Results of a Prospective Randomized Trial
David F. Scott et al.
JOURNAL OF ARTHROPLASTY (2013)
Reduction in the Risk of Clinical Fractures After a Single Dose of Zoledronic Acid 5 Milligrams
I. R. Reid et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Low BMD affects initial stability and delays stem osseointegration in cementless total hip arthroplasty in women A 2-year RSA study of 39 patients
Hannu T. Aro et al.
ACTA ORTHOPAEDICA (2012)
Five years of anti-resorptive activity after a single dose of zoledronate - Results from a randomized double-blind placebo-controlled trial
Andrew Grey et al.
BONE (2012)
Measurement of aminoterminal propeptide of type I procollagen (PINP) in serum
Marja-Kaisa Koivula et al.
CLINICAL BIOCHEMISTRY (2012)
Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis
Emmanuel Biver et al.
JOINT BONE SPINE (2012)
The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
Dennis M. Black et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Bisphosphonates for periprosthetic bone loss after joint arthroplasty: a meta-analysis of 14 randomized controlled trials
T. Lin et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Clinical Use of Bone Turnover Markers to Monitor Pharmacologic Fracture Prevention Therapy
John T. Schousboe et al.
CURRENT OSTEOPOROSIS REPORTS (2012)
What is the optimal duration of bisphosphonate therapy?
Susan M. Ott
CLEVELAND CLINIC JOURNAL OF MEDICINE (2011)
The Effect of Weekly Risedronate on Periprosthetic Bone Resorption Following Total Hip Arthroplasty A Randomized, Double-Blind, Placebo-Controlled Trial
Olof Gustaf Skoldenberg et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2011)
Efficacy and safety of monthly ibandronate in men with low bone density
Eric S. Orwoll et al.
BONE (2010)
Postoperative use of bisphosphonates and risk of revision after primary total hip arthroplasty: A nationwide population-based study
Theis M. Thillemann et al.
BONE (2010)
Female patients with low systemic BMD are prone to bone loss in Gruen zone 7 after cementless total hip arthroplasty A 2-year DXA follow-up of 39 patients
Jessica J. Alm et al.
ACTA ORTHOPAEDICA (2009)
A randomised, double-blinded, placebo-controlled, trial to determine the individual response in bone turnover markers to lasofoxifene therapy
A. Rogers et al.
BONE (2009)
The Effect of a Single Infusion of Zoledronic Acid on Early Implant Migration in Total Hip Arthroplasty A Randomized, Double-Blind, Controlled Trial
Gerald Friedl et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2009)
Changes of Femoral Periprosthetic Bone Mineral Density 6 Years after Treatment with Alendronate following Total Hip Arthroplasty
Mohammad Arabmotlagh et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2009)
Biomarkers for osteoporosis management - Utility in diagnosis, fracture risk prediction and therapy monitoring
Patrick Garnero
MOLECULAR DIAGNOSIS & THERAPY (2008)
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
R. G. G. Russell et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Does bone quality predict loosening of cemented total hip replacements?
M. Nixon et al.
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME (2007)
Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate
Michael McClung et al.
BONE (2007)
A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density
Kenneth Saag et al.
BONE (2007)
Clinical and radiological outcome of total hip replacement five years after pamidronate therapy - A trial extension
N. Shetty et al.
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME (2006)
Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty -: A meta-analysis
M Bhandari et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2005)
Monitoring of periprosthetic BMD after uncemented total hip arthroplasty with dual-energy X-ray absorptiometry -: a 3-year follow-up study
PK Venesmaa et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
分享论文
